More signs of alignment between startups, pharma, and payers.
Leo Grimaldi, MD
Advertisement
Articles by Leo Grimaldi, MD
Pharma companies are increasingly turning to tech enabled behavioral-based interventions to help improve patient outcomes through their diagnosis, treatment, and coordination of care.
Advertisement
Latest Updated Articles
Digital Therapeutics Can Break Down Barriers to Innovation to Benefit PatientsPublished: June 19th 2019 | Updated:
The Shrinking Disconnect in Digital TherapeuticsPublished: August 1st 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pharma and MedTech Rarely Collide. That Might Be the Biggest Miss in Healthcare
2
Insilico Medicine Enters $120 Million Drug Development Collaboration with Qilu Pharmaceuticals to Advance Cardiometabolic Therapies
3
Public Citizen Files Suit Against Trump Administration for Undisclosed Details of Pfizer and Eli Lilly Drug-Pricing Deals: Report
4
FDA Approves Yuvezzi to Treat Presbyopia in Adults
5